Liminatus Pharma (LIMN) Stock Chart & Stock Price History $3.25 -0.15 (-4.41%) As of 04:00 PM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsFDA EventsSEC FilingsTrendsBuy This Stock Liminatus Pharma Stock Price Performance The Liminatus Pharma (LIMN) stock chart highlights key performance trends across multiple timeframes. In the past month, the stock has decreased 62.69%, reflecting recent market activity. As of the latest close, Liminatus Pharma traded at $3.40 with a market cap of $88.43 million and volume of 1.62 million shares. Receive LIMN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Liminatus Pharma and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance+16.91%1 Month Performance-62.69% LIMN Stock Chart for Tuesday, August, 26, 2025 LIMN Chart by TradingView Liminatus Pharma Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/25/2025$3.41$3.40-0.29%$3.60$2.931.62 million shs$88.43 million08/22/2025$2.78$3.41+22.66%$4.06$3.0935.51 million shs$88.69 million08/21/2025$3.34$2.78-16.77%$3.31$2.531.27 million shs$72.32 million08/20/2025$3.86$3.34-13.47%$3.87$3.28464,438 shs$86.87 million08/19/2025$3.97$3.86-2.77%$4.00$3.77244,711 shs$100.40 million08/18/2025$4.00$3.97-0.75%$4.12$3.94191,926 shs$103.26 million08/15/2025$4.12$4.00-2.91%$4.33$3.70927,728 shs$104.04 million08/14/2025$4.40$4.12-6.36%$4.85$4.081.05 million shs$107.18 million08/13/2025$4.35$4.40+1.15%$4.69$4.10316,634 shs$114.44 million08/12/2025$4.48$4.35-2.90%$4.59$4.27122,296 shs$113.14 million Get the Latest News and Ratings for LIMN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Liminatus Pharma and its competitors with MarketBeat's FREE daily newsletter. 08/11/2025$4.42$4.48+1.36%$4.59$4.40146,539 shs$116.55 million08/08/2025$4.83$4.42-8.49%$4.76$4.39322,719 shs$114.99 million08/07/2025$4.70$4.83+2.77%$4.87$4.70128,616 shs$125.63 million08/06/2025$4.94$4.70-4.86%$5.06$4.60214,984 shs$122.25 million08/05/2025$5.09$4.94-2.95%$5.18$4.64229,670 shs$128.51 million08/04/2025$5.93$5.09-14.17%$6.31$4.20829,298 shs$132.39 million08/01/2025$6.27$5.93-5.42%$6.28$5.85171,387 shs$154.24 million07/31/2025$6.78$6.27-7.52%$6.84$6.10211,118 shs$163.08 million07/30/2025$6.69$6.78+1.35%$7.10$6.66316,940 shs$176.38 million07/29/2025$8.08$6.69-17.20%$8.06$6.63502,501 shs$174.01 million07/28/2025$8.71$8.08-7.23%$8.89$7.70712,493 shs$210.16 million07/25/2025$8.47$8.71+2.83%$9.38$7.90970,079 shs$226.55 million Related Companies Benitec Biopharma Stock Chart Aldeyra Therapeutics Stock Chart Amarin Stock Chart Capricor Therapeutics Stock Chart CytomX Therapeutics Stock Chart Altimmune Stock Chart 4D Molecular Therapeutics Stock Chart Tonix Pharmaceuticals Stock Chart Larimar Therapeutics Stock Chart DiaMedica Therapeutics Stock Chart Receive LIMN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Liminatus Pharma and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:LIMN) was last updated on 8/26/2025 by MarketBeat.com Staff From Our Partners“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredCover all your expenses with just $118,000 invested?Generate up to $5,000/month with 10X less money? That's what every financial advisor tells you. But I just ...Investors Alley | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredFed Decision Warning: How to Protect Your Wealth Before September 30th On September 17th, the Fed faces an impossible choice—and Wall Street insiders are already preparing for the...American Alternative | SponsoredTrump’s SHOCKING Plan to Create MASSIVE Wealth for AmericansJames Altucher says Donald Trump just made a move so surprising, it could go down as the most lucrative presid...Paradigm Press | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Liminatus Pharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Liminatus Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access